Triska, Jeffrey http://orcid.org/0000-0003-4476-7994
Maitra, Neil
Deshotels, Matthew R.
Haddadin, Faris
Angiolillo, Dominick J.
Vilahur, Gemma
Jneid, Hani
Atar, Dan
Birnbaum, Yochai
Funding for this research was provided by:
John S. Dunn Foundation (B2017/BMD-3738)
Article History
Accepted: 12 August 2022
First Online: 24 August 2022
Declarations
:
: N/A.
: N/A.
: N/A.
: Dominick Angiolillo declares that he has received consulting fees or honoraria from Abbott, Amgen, AstraZeneca, Bayer, Biosensors, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Daiichi-Sankyo, Eli Lilly, Haemonetics, Janssen, Merck, PhaseBio, PLx Pharma, Pfizer, and Sanofi. He also declares that his institution has received research grants from Amgen, AstraZeneca, Bayer, Biosensors, CeloNova, CSL Behring, Daiichi-Sankyo, Eisai, Eli Lilly, Gilead, Idorsia, Janssen, Matsutani Chemical Industry Co., Merck, Novartis, Osprey Medical, Renal Guard Solutions, and the Scott R. MacKenzie Foundation. Gemma Vilahur is the recipient of an unrestricted research grant from Astra Zeneca. Dan Atar declares that he received a speaker honoraria and consultancy fees from AstraZeneca and Bayer Healthcare and research grants to the institution from Bayer Healthcare. Yochai Birnbaum received research grants from Astra Zeneca for ticagrelor and dapagliflozin. The remaining authors have no declarations.